Androgen Insensitivity Syndrome

Total Page:16

File Type:pdf, Size:1020Kb

Androgen Insensitivity Syndrome View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of East Anglia digital repository Seminar Androgen insensitivity syndrome Ieuan A Hughes, John D Davies, Trevor I Bunch, Vickie Pasterski, Kiki Mastroyannopoulou, Jane MacDougall Androgen insensitivity syndrome in its complete form is a disorder of hormone resistance characterised by a female Lancet 2012; 380: 1419–28 phenotype in an individual with an XY karyotype and testes producing age-appropriate normal concen trations of Published Online androgens. Pathogenesis is the result of mutations in the X-linked androgen receptor gene, which encodes for the June 13, 2012 ligand-activated androgen receptor—a transcription factor and member of the nuclear receptor superfamily. This http://dx.doi.org/10.1016/ S0140-6736(12)60071-3 Seminar describes the clinical manifestations of androgen insensitivity syndrome from infancy to adulthood, reviews Department of Paediatrics, the mechanism of androgen action, and shows examples of how mutations of the androgen receptor gene cause the University of Cambridge, syndrome. Management of androgen insensitivity syndrome should be undertaken by a multidisciplinary team and Cambridge, UK include gonadectomy to avoid gonad tumours in later life, appropriate sex-hormone replacement at puberty and (Prof I A Hughes MD, beyond, and an emphasis on openness in disclosure. J D Davies PhD, T I Bunch, V Pasterski PhD, K Mastroyannopoulou BSc); Introduction menses. Development of oestrogen-dependent secondary and Section of Reproductive Several clinical disorders arise because of complete sexual characteristics occurs as the result of excess Medicine, Department of Obstetrics and Gynaecology, or partial resistance to the action of hormones.1 aromatisation of androgens. Pubic and axillary hair is Addenbrooke’s Hospital, 2 Examples include diabetes due to insulin resistance usually absent or can be present in sparse amounts. No Cambridge, UK and reproductive disorders caused by resistance to precise fi gures are available for the prevalence of (J MacDougall MD) 3 gonadotropin and steroid hormones. Male development complete androgen insensitivity syn drome, but estimates Correspondence to: during fetal life occurs only when an XY zygote directs range from one in 20 400 to one in 99 100 genetic males Prof Ieuan A Hughes, the bipotential gonad to become a testis (sex deter- on the basis of a proven molecular diagnosis.7 Department of Paediatrics, University of Cambridge, mination), which in turn secretes suffi cient amounts of In infancy, complete androgen insensitivity syndrome Addenbrooke’s Hospital, Hills active androgen to produce the male phenotype (sex presents as an inguinal hernia or labial swelling containing Road, Cambridge CB2 0QQ, UK diff erentiation).4 Figure 1 shows the pathway of healthy a testis in an apparently female infant. Bilateral inguinal [email protected] male and female fetal sex development, modifi ed to herniae are rare in female infants—the incidence of include complete resistance to the action of androgens complete androgen insensitivity syndrome in such resulting in a female phenotype—ie, a hormone- patients is 1–2% during infancy.8,9 Clinicians recommend resistance syndrome. that karyotyping or a biopsy of a gonad within the hernial Hormone-resistance syndrome was fully characterised sac is done after the parents give consent.10 Alternatively, by John Morris, who reviewed the clinical features of vaginal length can be measured in prepubertal girls 82 patients.5 Because the patients were women and girls undergoing inguinal hernia repair to screen for complete with bilateral testes that seemed to produce oestrogen-like androgen in sensitivity syndrome;9 a shortened vagina and hormones, Morris coined the term testicular feminisation the absence of ovaries or fallopian tubes suggests the need syndrome. This contradictory label was renamed as for karyotyping. The uterus, cervix, and proximal vagina complete androgen insensitivity syndrome, which is now are absent in complete androgen insensitivity syndrome the accepted terminology.6 Partial androgen insensitivity because of the action of antimüllerian hormone produced syndrome refers to a phenotype of varying degrees of by Sertoli cells of the testis.4 The vagina varies from a masculinisation of the external genitalia due to partial dimple in the perineum to normal length, but is always androgen responsiveness. Mild androgen insensitivity blind-ending. Occasionally, older sisters of people with syndrome is reported in healthy men and boys who can complete androgen insensitivity syndrome have also had present with adolescent gynaecomastia or infertility in later life. Thus, androgen insensitivity syndrome can be defi ned as a disorder resulting from complete or partial Search strategy and selection criteria resistance to the biological actions of androgens in an XY We searched PubMed mainly with the search terms man or boy with normal testis determination and “androgen insensitivity syndrome” in combination with the production of age-appropriate androgen concentrations. additional terms “complete” and “partial”. For the molecular The pathophysi ology of this syndrome is based on the section, we searched for the terms “androgen receptor”, mechanism of action of androgens (appendix). “androgen receptor mutation”, “nuclear receptor”, and See Online for appendix “nuclear receptor co-regulators”. For the management Complete androgen insensitivity syndrome section, we used the terms “germ cell tumours”, “hormone Clinical presentation replacement therapy”, “vaginal dilators”, and “gender The typical presentation for complete androgen insensi- identity”. We selected publications from the past 10 years, but tivity syndrome is either primary amenorrhoea in older papers related to fi rst descriptions of the syndrome are adolescence, or inguinal swellings in an infant. A female cited, as are relevant review articles from monographs and adolescent with the disorder has breast development and book chapters. a pubertal growth spurt at the appropriate age, but no www.thelancet.com Vol 380 October 20, 2012 1419 Seminar Zygote at fertilisation for men and boys and luteinising hormone (LH) concen trations are inappropriately increased.19 Con cen- Bipotential gonad trations of follicle-stimulating hormone and inhibin are gener ally normal. Excess testosterone is produced and peripherally aromatised to oestrogen which, together with LH-induced direct secretion of testicular oestrogen, XY XX results in serum oestradiol concentrations higher than Testis Ovary those noted in men and boys but lower than those reported in women without complete androgen insensi- tivity syndrome.20 Serum gonadotropin concentrations AMH No AMH No müllerian ducts Müllerian ducts increase further after gonadectomy, but are only CAIS partly suppressed with oestrogen substitution. These Wolffian ducts; Androgens/AR No androgens No wolffian ducts; male genitalia female genitalia fi ndings suggest resistance to the negative-feedback No AR eff ect of androgens on hypothalamic–pituitary control Male phenotype Female phenotype of gonadotropin secretion in complete androgen in- Figure 1: Simplifi ed pathway of fetal sex development sensitivity syndrome, but maintenance of a partial AR=androgen receptor. CAIS=complete androgen insensitivity syndrome. AMH=antimüllerian hormone. negative feedback by oestrogens. Concentrations of sex- hormone-binding globulin are sexually dimorphic; androgens decrease and oestrogens increase hepatic an inguinal hernia repair in infancy, and can have a 46,XY production, respectively. Concentrations of this protein karyotype (unpublished). in patients with complete androgen insensitivity Diagnosis of complete androgen insensitivity syn- syndrome are similar to those in women without drome can happen by chance. The sex of a fetus is now the syndrome and do not decrease after androgen increasingly known before birth through analysis of administration.21 karyotypes, chorionic villi, amniotic fl uid samples, or The pattern of gonadotropin and testosterone con- maternal circulating free fetal DNA,11 and use of three- centrations is less suggestive of hormone resistance dimensional ultrasonography. Complete androgen when complete androgen insensitivity syndrome pre- insen sitivity syndrome can therefore some times be diag- sents in infancy.22,23 Usually, LH-induced serum testos- nosed as a result of mismatch between the prenatal sex terone concentrations surge during the fi rst few months prediction and the phenotype at birth.12 Other modes of of life—a so-called mini-puberty.24,25 This profi le, however, presentation include a known family history of X-linked cannot be used to diagnose complete androgen in- complete androgen insensitivity syndrome and, sensitivity syndrome in many infants, although serum occasion ally, the discovery of a pelvic mass arising from testosterone concentrations do increase appropriately a gonadal tumour.13 after stimulation with human chorionic gonadotropin.22 Adult women with complete androgen insensitivity Infants with partial androgen insensitivity syndrome syndrome are generally taller than women without have a more responsive pattern of LH and testosterone, the syndrome, but are on average shorter than the male both basally and after stimulation with human chorionic population.14 Patients in whom gonadectomy is delayed gonadotropin. The human chorionic gonadotropin are even taller, suggesting a relative oestrogen defi ciency stimulation test is
Recommended publications
  • Clinical, Hormonal and Genetic Characteristics of Androgen Insensitivity Syndrome in 39 Chinese Patients Qingxu Liu, Xiaoqin Yin and Pin Li*
    Liu et al. Reproductive Biology and Endocrinology (2020) 18:34 https://doi.org/10.1186/s12958-020-00593-0 RESEARCH Open Access Clinical, hormonal and genetic characteristics of androgen insensitivity syndrome in 39 Chinese patients Qingxu Liu, Xiaoqin Yin and Pin Li* Abstract Background: Abnormal androgen receptor (AR) genes can cause androgen insensitivity syndrome (AIS), and AIS can be classified into complete androgen insensitivity syndrome (CAIS), partial androgen insensitivity syndrome (PAIS) and mild AIS. We investigated the characteristics of clinical manifestations, serum sex hormone levels and AR gene mutations of 39 AIS patients, which provided deeper insight into this disease. Methods: We prospectively evaluated 39 patients with 46, XY disorders of sex development (46, XY DSD) who were diagnosed with AIS at the Department of Endocrinology of Shanghai Children’s Hospital from 2014 to 2019. We analysed clinical data from the patients including hormone levels and AR gene sequences. Furthermore, we screened the AR gene sequences of the 39 AIS patients to identify probable mutations. Results: The 39 AIS patients came from 37 different families; 19 of the patients presented CAIS, and 20 of them presented PAIS. The CAIS patients exhibited a higher cryptorchidism rate than the PAIS (100 and 55%, P = 0.001). There were no significant difference between the CAIS and PAIS groups regarding the levels of inhibin B (INHB), sex hormone-binding globulin (SHBG), basal luteinizing hormone (LH), testosterone (T), or basal dihydrotestosterone (DHT), the T:DHT ratio, DHT levels after human chorionic gonadotropin (HCG) stimulation or T levels after HCG stimulation. However, the hormone levels of AMH (P = 0.010), peak LH (P = 0.033), basal FSH (P = 0.009) and peak FSH (P = 0.033) showed significant differences between the CAIS group and the PAIS group.
    [Show full text]
  • 139 Normal Bone Density in Male
    SEPTEMBER-OCTOBER REV. HOSP. CLÍN. FAC. MED. S. PAULO 56(5):139-142, 2001 NORMAL BONE DENSITY IN MALE PSEUDOHERMAPHRODITISM DUE TO 5α- REDUCTASE 2 DEFICIENCY Elaine Maria Frade Costa, Ivo Jorge Prado Arnhold, Marlene Inacio and Berenice Bilharinho Mendonca RHCFAP/3050 COSTA EMF et al. - Normal bone density in male pseudohermaphroditism due to 5α-reductase 2 deficiency. Rev. Hosp. Clín. Fac. Med. S. Paulo 56(5):139-142, 2001. Bone is an androgen-dependent tissue, but it is not clear whether the androgen action in bone depends on testosterone or on dihydrotestosterone. Patients with 5α-reductase 2 deficiency present normal levels of testosterone and low levels of dihydrotestosterone, providing an in vivo human model for the analysis of the effect of testosterone on bone. Objective: To analyze bone mineral density in 4 adult patients with male pseudohermaphroditism due to 5α-reductase 2 deficiency. Results: Three patients presented normal bone mineral density of the lumbar column (L1-L4) and femur neck, and the other patient presented a slight osteopenia in the lumbar column. Conclusion: Patients with dihydrotestosterone deficiency present normal bone mineral density, suggesting that dihydrotestosterone is not the main androgen acting in bone. DESCRIPTOR: Bone mineral density. Male pseudohermaphroditism. 5α-reductase type 2 deficiency. It has been well documented in the fied androgenic receptors in these cells, fects require aromatization into estro- literature that gonadal steroids regulate thus demonstrating that both androgens gens with subsequent activation of the normal bone metabolism and that in- and estrogens act by a direct mecha- estrogenic receptor. Although it has adequate estrogen concentrations in fe- nism through their respective receptors.
    [Show full text]
  • Hyperplasia (Growth Factors
    Adaptations Robbins Basic Pathology Robbins Basic Pathology Robbins Basic Pathology Coagulation Robbins Basic Pathology Robbins Basic Pathology Homeostasis • Maintenance of a steady state Adaptations • Reversible functional and structural responses to physiologic stress and some pathogenic stimuli • New altered “steady state” is achieved Adaptive responses • Hypertrophy • Altered demand (muscle . hyper = above, more activity) . trophe = nourishment, food • Altered stimulation • Hyperplasia (growth factors, . plastein = (v.) to form, to shape; hormones) (n.) growth, development • Altered nutrition • Dysplasia (including gas exchange) . dys = bad or disordered • Metaplasia . meta = change or beyond • Hypoplasia . hypo = below, less • Atrophy, Aplasia, Agenesis . a = without . nourishment, form, begining Robbins Basic Pathology Cell death, the end result of progressive cell injury, is one of the most crucial events in the evolution of disease in any tissue or organ. It results from diverse causes, including ischemia (reduced blood flow), infection, and toxins. Cell death is also a normal and essential process in embryogenesis, the development of organs, and the maintenance of homeostasis. Two principal pathways of cell death, necrosis and apoptosis. Nutrient deprivation triggers an adaptive cellular response called autophagy that may also culminate in cell death. Adaptations • Hypertrophy • Hyperplasia • Atrophy • Metaplasia HYPERTROPHY Hypertrophy refers to an increase in the size of cells, resulting in an increase in the size of the organ No new cells, just larger cells. The increased size of the cells is due to the synthesis of more structural components of the cells usually proteins. Cells capable of division may respond to stress by undergoing both hyperrtophy and hyperplasia Non-dividing cell increased tissue mass is due to hypertrophy.
    [Show full text]
  • Reportable BD Tables Apr2019.Pdf
    April 2019 Georgia Department of Public Health | Division of Health Protection | Maternal and Child Health Epidemiology Unit Reportable Birth Defects with ICD-10-CM Codes Reportable Birth Defects in Georgia with ICD-10-CM Diagnosis Codes Table D.1 Brain Malformations and Neural Tube Defects ICD-10-CM Diagnosis Codes Birth Defect ICD-10-CM 1. Brain Malformations and Neural Tube Defects Q00-Q05, Q07 Anencephaly Q00.0 Craniorachischisis Q00.1 Iniencephaly Q00.2 Frontal encephalocele Q01.0 Nasofrontal encephalocele Q01.1 Occipital encephalocele Q01.2 Encephalocele of other sites Q01.8 Encephalocele, unspecified Q01.9 Microcephaly Q02 Malformations of aqueduct of Sylvius Q03.0 Atresia of foramina of Magendie and Luschka (including Dandy-Walker) Q03.1 Other congenital hydrocephalus (including obstructive hydrocephaly) Q03.8 Congenital hydrocephalus, unspecified Q03.9 Congenital malformations of corpus callosum Q04.0 Arhinencephaly Q04.1 Holoprosencephaly Q04.2 Other reduction deformities of brain Q04.3 Septo-optic dysplasia of brain Q04.4 Congenital cerebral cyst (porencephaly, schizencephaly) Q04.6 Other specified congenital malformations of brain (including ventriculomegaly) Q04.8 Congenital malformation of brain, unspecified Q04.9 Cervical spina bifida with hydrocephalus Q05.0 Thoracic spina bifida with hydrocephalus Q05.1 Lumbar spina bifida with hydrocephalus Q05.2 Sacral spina bifida with hydrocephalus Q05.3 Unspecified spina bifida with hydrocephalus Q05.4 Cervical spina bifida without hydrocephalus Q05.5 Thoracic spina bifida without
    [Show full text]
  • CYP19A1 Gene Cytochrome P450 Family 19 Subfamily a Member 1
    CYP19A1 gene cytochrome P450 family 19 subfamily A member 1 Normal Function The CYP19A1 gene provides instructions for making an enzyme called aromatase. This enzyme converts a class of hormones called androgens, which are involved in male sexual development, to different forms of the female sex hormone estrogen. In cells, aromatase is found in a structure called the endoplasmic reticulum, which is involved in protein production, processing, and transport. The activity (expression) of aromatase varies among different cell types depending on the cells' need for estrogen. In females, aromatase is most active in the ovaries, where it guides sexual development. In males, aromatase is most active in fat (adipose) tissue. In both males and females, estrogen plays a role in regulating bone growth and blood sugar levels. During fetal development, aromatase converts androgens to estrogens in the placenta, which is the link between the mother's blood supply and the fetus. This conversion in the placenta prevents androgens from directing sexual development in female fetuses. After birth, the conversion of androgens to estrogens takes place in multiple tissues. Health Conditions Related to Genetic Changes Aromatase deficiency More than 20 mutations in the CYP19A1 gene have been found to cause aromatase deficiency. This condition is characterized by reduced levels of estrogen and increased levels of androgens. These abnormal hormone levels lead to impaired sexual development in affected females and unusual bone growth, insulin resistance, and other signs and symptoms in both males and females with the condition. CYP19A1 gene mutations that cause aromatase deficiency decrease or eliminate aromatase activity. A lack of aromatase function results in an inability to convert androgens to estrogens before birth and throughout life.
    [Show full text]
  • Multiple Congenital Genitourinary Anomalies in a Polled Goat
    Multiple Congenital Genitourinary Anomalies in a Polled Goat WILLIAM W. KING, DVM, PHD, DIPLOMATE, ACLAM,1,2* MELVIN E. YOUNG,1 AND M. EUGENE FOX, DVM3 A 1-day-old, Toggenburg/Nubian crossbred goat of polled parentage was referred for necropsy because of a large (diameter, 5 cm) bladder-like mass protruding from the perineal midline and difficult urination. Differential diagnoses included cutaneous cyst, ectopic urinary bladder, and urethral diverticulum/dilatation. Several genitourinary aberrations were noted. A second, smaller (diameter, 1 cm), more distal cystic structure was adjacent to an ambiguous prepuce. Testicles were discovered within a con- stricted, subcutaneous space near the inguinal canals. A rudimentary penis was located dorsal to the penile urethra with no appreciable urethral process. A tiny external urethral orifice was discerned only after liquid was injected into the lumen of the cystic structures, confirming their identity as urethral dilatations. The dilatations were separated by a constricting band of fibrous tissue. No other significant findings were detected. This case illustrates a combination of congenital anomalies including bilateral cryptorchidism with scrotal absence, segmental urethral hypoplasia, and urethral dilatation, most likely associated with the intersex condition seen in polled breeds. The continued production and use of small ruminants as animal models demands the prompt recognition of congenital anomalies. This case also exemplifies the precautions required when breeding goats with polled ancestry. The domestic goat (Capra hircus) has historically served and Nubian/Toggenburg sire. The owner reported that the doe had continues to play an important role in biomedical research (1). completed a normal gestation period on a diet of natural grass/ Many small breeds are available, facilitating common labora- alfalfa hay and water.
    [Show full text]
  • Chapter 1 Cellular Reaction to Injury 3
    Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1).
    [Show full text]
  • CELL INJURY MEDICAL (Lecture 1)
    CELL INJURY MEDICAL (lecture 1) Sufia Husain Assistant Prof & Consultant College of Medicine, KSU, Riyadh. September 2015 Objectives for Cell Injury Chapter (3 lectures) The students should: A. Understand the concept of cells and tissue adaptation to environmental stress including the meaning of hypertrophy, hyperplasia, aplasia, atrophy, hypoplasia and metaplasia with their clinical manifestations. B. Is aware of the concept of hypoxic cell injury and its major causes. C. Understand the definitions and mechanisms of free radical injury. D. Knows the definition of apoptosis, tissue necrosis and its various types with clinical examples. E. Able to differentiate between necrosis and apoptosis. F. Understand the causes of and pathologic changes occurring in fatty change (steatosis), accumulations of exogenous and endogenous pigments (carbon, silica, iron, melanin, bilirubin and lipofuscin). G. Understand the causes of and differences between dystrophic and metastatic calcifications. Lecture 1 outline . Adaptation to environmental stress: hypertrophy, hyperplasia, aplasia, hypoplasia, atrophy, squamous metaplasia, osseous metaplasia and myeloid metaplasia. Hypoxic cell injury and its causes (ischaemia, anaemia, carbon monoxide poisoning, decreased perfusion of tissues by oxygen, carrying blood and poor oxygenation of blood). Free radical injury: definition of free radicals, mechanisms that generate free radicals, mechanisms that degrade free radicals. Reversible and irreversible cell injury ADAPTATION TO ENVIRONMENTAL STRESS Adaptation to environmental stress . Cells are constantly adjusting their structure and function to accommodate changing demands i.e. they adapt within physiological limits. As cells encounter physiologic stresses or pathologic stimuli, they can undergo adaptation. The principal adaptive responses are . hypertrophy, . hyperplasia, . atrophy, . metaplasia. (NOTE: If the adaptive capability is exceeded or if the external stress is harmful, cell injury develops.
    [Show full text]
  • Transgender Identity and Cryptorchidism: a Case Study
    ORIGINAL ARTICLE Volume 42, Issue 1, January-February 2019 doi: 10.17711/SM.0185-3325.2019.007 Transgender identity and cryptorchidism: A case study Tania Real Quintanar,1 Rebeca Robles García,1 María Elena Medina-Mora,1 Juan Carlos Jorge,2 Lucía Vázquez Pérez3 1 Centro de Investigación en Salud ABSTRACT Mental Global, Dirección de In- vestigaciones Epidemiológicas y There is a wide range of possible combinations in relation to sex at birth, gender identity, and Psicosociales, Instituto Nacional de Introduction. Psiquiatría Ramón de la Fuente Mu- sexual orientations. Specific medical and psychological treatment needs may also vary depending on these ñíz, Mexico City, Mexico. combinations. Objective. In order to promote interventions that focus on the perceived needs of those directly 2 Departamento de Anatomía y Neu- involved, the aim of the present case study is to describe the clinical and life experiences of a 43-year old trans- robiología, Escuela de Medicina, gender woman with cryptorchidism and examine the interplay between this relative common testicular problem Universidad de Puerto Rico, San at birth, gender identity, and sexual orientation formation processes from her own perspective. An Juan, Puerto Rico. Method. in-depth interview was conducted at a specialized care centre in Mexico City, Mexico. The interview was audio 3 Departamento de Investigaciones Epidemiológicas y Psicosociales, recorded and transcribed for a content analysis. Results. The case under analysis was assigned to the male Dirección de Investigaciones Epi- sex and identified herself as a transgender woman and lesbian. Although it is not possible to conclude that demiológicas y Psicosociales, Insti- her gender identity or sexual orientation is related to her antecedent of cryptorchidism, as she reflected on her tuto Nacional de Psiquiatría Ramón related negative experiences, she concluded that her gender identity and sexual orientation trajectories, as well de la Fuente Muñíz, Mexico City, Mexico.
    [Show full text]
  • Health and Wellbeing of People with Intersex Variations Information and Resource Paper
    Health and wellbeing of people with intersex variations Information and resource paper The Victorian Government acknowledges Victorian Aboriginal people as the First Peoples and Traditional Owners and Custodians of the land and water on which we rely. We acknowledge and respect that Aboriginal communities are steeped in traditions and customs built on a disciplined social and cultural order that has sustained 60,000 years of existence. We acknowledge the significant disruptions to social and cultural order and the ongoing hurt caused by colonisation. We acknowledge the ongoing leadership role of Aboriginal communities in addressing and preventing family violence and will continue to work in collaboration with First Peoples to eliminate family violence from all communities. Family Violence Support If you have experienced violence or sexual assault and require immediate or ongoing assistance, contact 1800 RESPECT (1800 737 732) to talk to a counsellor from the National Sexual Assault and Domestic Violence hotline. For confidential support and information, contact Safe Steps’ 24/7 family violence response line on 1800 015 188. If you are concerned for your safety or that of someone else, please contact the police in your state or territory, or call 000 for emergency assistance. To receive this publication in an accessible format, email the Diversity unit <[email protected]> Authorised and published by the Victorian Government, 1 Treasury Place, Melbourne. © State of Victoria, Department of Health and Human Services, March 2019 Victorian Department of Health and Human Services (2018) Health and wellbeing of people with intersex variations: information and resource paper. Initially prepared by T.
    [Show full text]
  • A Novel Null Mutation in P450 Aromatase Gene (CYP19A1
    J Clin Res Pediatr Endocrinol 2016;8(2):205-210 DO I: 10.4274/jcrpe.2761 Ori gi nal Ar tic le A Novel Null Mutation in P450 Aromatase Gene (CYP19A1) Associated with Development of Hypoplastic Ovaries in Humans Sema Akçurin1, Doğa Türkkahraman2, Woo-Young Kim3, Erdem Durmaz4, Jae-Gook Shin3, Su-Jun Lee3 1Akdeniz University Faculty of Medicine Hospital, Department of Pediatric Endocrinology, Antalya, Turkey 2Antalya Training and Research Hospital, Clinic of Pediatric Endocrinology, Antalya, Turkey 3 Inje University College of Medicine, Department of Pharmacology, Inje University, Busan, Korea 4İzmir University Faculty of Medicine, Medical Park Hospital, Clinic of Pediatric Endocrinology, İzmir, Turkey ABS TRACT Objective: The CYP19A1 gene product aromatase is responsible for estrogen synthesis and androgen/estrogen equilibrium in many tissues, particularly in the placenta and gonads. Aromatase deficiency can cause various clinical phenotypes resulting from excessive androgen accumulation and insufficient estrogen synthesis during the pre- and postnatal periods. In this study, our aim was to determine the clinical characteristics and CYP19A1 mutations in three patients from a large Turkish pedigree. Methods: The cases were the newborns referred to our clinic for clitoromegaly and labial fusion. Virilizing signs such as severe acne formation, voice deepening, and clitoromegaly were noted in the mothers during pregnancy. Preliminary diagnosis was aromatase deficiency. Therefore, direct DNA sequencing of CYP19A1 was performed in samples from parents (n=5) and patients (n=3). WHAT IS ALREADY KNOWN ON THIS TOPIC? Results: In all patients, a novel homozygous insertion mutation in the fifth exon (568insC) was found to cause a frameshift in the open reading frame and to truncate Aromatase deficiency can cause various clinical phenotypes the protein prior to the heme-binding region which is crucial for enzymatic activity.
    [Show full text]
  • Complete Androgen Insensitivity Syndrome in a Chinese Neonate
    HK J Paediatr (new series) 2004;9:248-252 Complete Androgen Insensitivity Syndrome in a Chinese Neonate MC HO, KL NG Abstract Complete androgen insensitivity syndrome (CAIS) is a rare X-linked disorder with a female external phenotype.1 We report on a Chinese baby with CAIS who presented with bilateral inguinal hernias. The baby has a normal female phenotype at birth. On further evaluation, the karyotype was found to be 46, XY. Endocrine findings were compatible with androgen insensitivity syndrome. Bilateral herniotomy was performed. We would review the literature, offer an overview of the disease, and discuss the outcome with emphasis on the treatment modalities. Key words Complete androgen insensitivity; Male pseudohermaphrodites Introduction investigations which, to the best of our knowledge, has not been reported on the literature.4 Herein we report a case of In 1953, an American gynaecologist JM Morris firstly CAIS in a Chinese neonate in the local region. described a series of individuals with androgen insensitivity syndrome (AIS).2 He reported that these individuals had normal female external genitalia, normal female breast Case Report development, absent or scant axillary and pubic hair, absent internal genital organs and undescended testes. AIS is the The patient was a Chinese baby born at full term by most common condition that results in male under- spontaneous vaginal delivery weighing 2.67 Kg. The masculinisation.3 It is caused by mutations in the androgen antenatal and postnatal course was uneventful. She was the receptor (AR) gene and encompasses a wide spectrum of first child born to the parents. There was no consanguinity male pseudohermaphroditisms.2 In complete androgen nor any significant family history, in particular there was insensitivity syndrome (CAIS), the function of the AR is no abnormal puberty nor infertility on the maternal side.
    [Show full text]